Davis FM - Search Results

1

Dermal and airway responses to monoclonal antibodies specific for canine IgE.

Groeben H, Lindeman KS, Davis FM, Cheng WI, Sampson HA, Hirshman CA. Groeben H, et al. Among authors: davis fm. Vet Immunol Immunopathol. 1997 Sep 19;58(3-4):209-18. doi: 10.1016/s0165-2427(97)00050-0. Vet Immunol Immunopathol. 1997. PMID: 9436265 Free article.

2

Effect of anti-IgE therapy in patients with peanut allergy.

Leung DY, Sampson HA, Yunginger JW, Burks AW Jr, Schneider LC, Wortel CH, Davis FM, Hyun JD, Shanahan WR Jr; Avon Longitudinal Study of Parents and Children Study Team. Leung DY, et al. Among authors: davis fm. N Engl J Med. 2003 Mar 13;348(11):986-93. doi: 10.1056/NEJMoa022613. Epub 2003 Mar 10. N Engl J Med. 2003. PMID: 12637608 Free article. Clinical Trial.

3

In vitro regulation of FcepsilonRIalpha expression on human basophils by IgE antibody.

MacGlashan D Jr, McKenzie-White J, Chichester K, Bochner BS, Davis FM, Schroeder JT, Lichtenstein LM. MacGlashan D Jr, et al. Among authors: davis fm. Blood. 1998 Mar 1;91(5):1633-43. Blood. 1998. PMID: 9473229 Free article.

4

Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases.

Chang TW, Davis FM, Sun NC, Sun CR, MacGlashan DW Jr, Hamilton RG. Chang TW, et al. Among authors: davis fm. Biotechnology (N Y). 1990 Feb;8(2):122-6. doi: 10.1038/nbt0290-122. Biotechnology (N Y). 1990. PMID: 1369991

5

Can anti-IgE be used to treat allergy?

Davis FM, Gossett LA, Pinkston KL, Liou RS, Sun LK, Kim YW, Chang NT, Chang TW, Wagner K, Bews J, et al. Davis FM, et al. Springer Semin Immunopathol. 1993;15(1):51-73. doi: 10.1007/BF00204626. Springer Semin Immunopathol. 1993. PMID: 8362344 Review.

6

Humanized anti-IgE mAb Hu-901 prevents the activation of allergen-specific T cells.

van Neerven RJ, van Roomen CP, Thomas WR, de Boer M, Knol EF, Davis FM. van Neerven RJ, et al. Among authors: davis fm. Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):400-2. doi: 10.1159/000053770. Int Arch Allergy Immunol. 2001. PMID: 11307028

7

The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics.

Corne J, Djukanovic R, Thomas L, Warner J, Botta L, Grandordy B, Gygax D, Heusser C, Patalano F, Richardson W, Kilchherr E, Staehelin T, Davis F, Gordon W, Sun L, Liou R, Wang G, Chang TW, Holgate S. Corne J, et al. J Clin Invest. 1997 Mar 1;99(5):879-87. doi: 10.1172/JCI119252. J Clin Invest. 1997. PMID: 9062345 Free PMC article. Clinical Trial.

8

Efficacy, pharmacodynamics, and pharmacokinetics of CGP 51901, an anti-immunoglobulin E chimeric monoclonal antibody, in patients with seasonal allergic rhinitis.

Racine-Poon A, Botta L, Chang TW, Davis FM, Gygax D, Liou RS, Rohane P, Staehelin T, van Steijn AM, Frank W. Racine-Poon A, et al. Among authors: davis fm. Clin Pharmacol Ther. 1997 Dec;62(6):675-90. doi: 10.1016/S0009-9236(97)90087-4. Clin Pharmacol Ther. 1997. PMID: 9433396 Clinical Trial.

9

An epitope on membrane-bound but not secreted IgE: implications in isotype-specific regulation.

Davis FM, Gossett LA, Chang TW. Davis FM, et al. Biotechnology (N Y). 1991 Jan;9(1):53-6. doi: 10.1038/nbt0191-53. Biotechnology (N Y). 1991. PMID: 1370037

10

Transfectomas expressing both secreted and membrane-bound forms of chimeric IgE with anti-viral specificity.

Sun LK, Liou RS, Sun NC, Gossett LA, Sun C, Davis FM, MacGlashan DW Jr, Chang TW. Sun LK, et al. Among authors: davis fm. J Immunol. 1991 Jan 1;146(1):199-205. J Immunol. 1991. PMID: 1701791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters